Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

Professor Alison Simmons

Professor Alison Simmons FMedSci will start as Director of the Medical Research Council Human Immunology Unit (MRC HIU) from the 18 January 2021.

The MRC HIU aims to further our understanding of how the immune system functions to develop better treatment strategies against infectious diseases, cancer, allergy and autoimmune diseases. The Unit’s research spans basic to translational immunology focussed on the development of experimental medicine programmes.

Professor Simmons said: “I am delighted to be appointed as Director of the MRC Human Immunology Unit. The MRC HIU has a long and auspicious history of fundamental immune breakthroughs, pioneering the field of human immunology and extending discovery across a wide range of human immune and infectious diseases.

Recently, state of the art technological advances have led to description of immune pathogenesis in human tissues in unprecedented depth. This opens whole new possibilities to harness the immune system for health and in the HIU we hope to bridge that gap over the coming years. Our unique grouping of clinical, basic science and computational expertise will enable us to tackle these problems to drive innovation.”

The full story is available on the MRC Weatherall Institute of Molecular Medicine website

Similar stories

Communication at the crossroads of the immune system

In his inaugural article in the Proceedings of the National Academy of Sciences as an NAS member (elected 2021), Prof Mike Dustin and his research team in Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences have explained how messages are passed across the immunological synapse. The research could have implications for future vaccine development and immunotherapy treatments.

Showcase success for Science Together research

A local collaboration teaming researchers from the University of Oxford and Oxford Brookes University with the Urban Music Foundation finished on a high note with an immersive sound and art installation at Oxford’s Old Fire Station.

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

COVID-19 is a leading cause of death in children and young people in the US

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

Three or more concussions linked with worse brain function in later life

Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.

New blood test could save lives of heart attack victims

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.